Edition:
United States

Oasmia Pharmaceutical AB (OASM.ST)

OASM.ST on Stockholm Stock Exchange

5.36SEK
16 Aug 2018
Change (% chg)

0.07kr (+1.32%)
Prev Close
5.29kr
Open
5.33kr
Day's High
5.38kr
Day's Low
5.30kr
Volume
21,609
Avg. Vol
1,422,131
52-wk High
7.92kr
52-wk Low
2.19kr

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Apr-18 1 8.00 8.00 8.00 --
Year Ending Apr-19 1 48.00 48.00 48.00 198.00
Year Ending Apr-20 1 383.00 383.00 383.00 484.00
Earnings (per share)
Year Ending Apr-18 1 -0.69 -0.69 -0.69 --
Year Ending Apr-19 1 -0.54 -0.54 -0.54 -0.48
Year Ending Apr-20 1 0.35 0.35 0.35 0.64
Sales and Profit Figures in Swedish Krona (SEK);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 28.12 30.20
P/E High - Last 5 Yrs. -- 42.03 47.09
P/E Low - Last 5 Yrs. -- 23.72 24.83
Beta 1.03 0.87 0.85
Price to Sales (TTM) 299.23 3.58 8.01
Price to Book (MRQ) 2.70 3.34 3.71
Price to Tangible Book (MRQ) -- 4.81 5.64
Price to Cash Flow (TTM) -- 19.79 21.20
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.93 1.79
Dividend Yield - 5 Year Avg 0.00 1.54 1.46
Dividend 5 Year Growth Rate -- -9.11 -6.24
Payout Ratio(TTM) -- 49.41 46.65

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 1,815.91 4.60 7.19
Sales (TTM) vs TTM 1 Yr. Ago 1,743.02 10.08 11.35
Sales - 5 Yr. Growth Rate -- 6.99 7.60
EPS (MRQ) vs Qtr. 1 Yr. Ago 47.23 18.36 23.75
EPS (TTM) vs TTM 1 Yr. Ago 48.03 -- --
EPS - 5 Yr. Growth Rate -- 6.42 7.55
Capital Spending - 5 Yr. Growth Rate -19.03 7.50 8.07

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.32 2.55 2.52
Current Ratio (MRQ) 0.36 3.61 3.57
LT Debt to Equity (MRQ) -- 8.80 11.14
Total Debt to Equity (MRQ) 54.27 11.21 14.09
Interest Coverage (TTM) -7.11 36.51 31.45

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 249.94 55.52 55.05
Gross Margin - 5 Yr. Avg. 591.85 53.23 53.19
EBITD Margin (TTM) -3,110.57 -- --
EBITD - 5 Yr. Avg -4,706.08 18.75 15.79
Operating Margin (TTM) -3,272.08 14.49 -2.37
Operating Margin - 5 Yr. Avg. -4,924.11 14.39 10.97
Pre-Tax Margin (TTM) -3,722.81 14.77 -0.49
Pre-Tax Margin - 5 Yr. Avg. -5,423.88 14.63 11.14
Net Profit Margin (TTM) -3,722.81 11.39 -3.70
Net Profit Margin - 5 Yr. Avg. -5,423.88 10.93 7.49
Effective Tax Rate (TTM) -- 20.45 20.42
Effective Tax Rate - 5 Yr. Avg. -- 23.83 24.17

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 843,415,010 736,176,668
Net Income/Employee (TTM) -- 98,389,061 85,788,783
Receivable Turnover (TTM) 3.93 5.45 5.43
Inventory Turnover (TTM) -0.41 2.47 3.56
Asset Turnover (TTM) 0.01 0.86 0.84

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -21.66 10.46 10.17
Return on Assets - 5 Yr. Avg. -25.38 11.53 11.04
Return on Investment (TTM) -36.57 13.07 12.77
Return on Investment - 5 Yr. Avg. -39.72 14.95 14.26
Return on Equity (TTM) -36.57 15.04 14.92
Return on Equity - 5 Yr. Avg. -39.75 16.20 15.59
  1 Year 3 Year 5 Year
Sales % 1,742.44 15.25 --
EPS (TTM) % 48.81 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Oasmia Pharmaceutical AB

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 13.64 12.45 99 34
13 Week 33.25 32.55 99 53
26 Week 34.95 27.88 99 23
52 Week 81.16 71.22 99 15
YTD 101.91 95.00 99 24
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 5.61%
# of Holders: 8
Total Shares Held: 10,066,113
3 Mo. Net Change: -2,165,829
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 0
# Reduced Positions: 4
# Net Buyers: -4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.